Neurology
Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}

      • Device-assisted therapy selection

      About aPD
      Identifying aPD
      Manage PD
      DAT Selection

      Symptom-based considerations for DAT selection

      There are several considerations when starting patients on a device-assisted therapy (DAT).1,2,3 A/Prof. John O’Sullivan, Director of the Movement Disorders Service at the Royal Brisbane and Womens’ Hospital outlines some of these in the following short video segments.

      The Evidence in Practice video series chaired by A/Prof. John O'Sullivan* and Dr Barry Vieira† contain highlights from our Australian webinar held on 30 August 2021.

      These considerations are not exhaustive. Please refer to the relevant Product Information and device instructions for use prior to prescribing.

      Symptom-guided selection of DAT
       

      DAT considerations based on
      neuropsychiatric status

      DAT considerations based on cognitive function
       

      DAT considerations based on presence/
      history of depression

      DAT considerations based on speech, postural
      and gait problems

      DAT considerations based on restless leg or
      orthostatic hypotension

      Contact a representative
      Contact a representative

      All content is intended only for informational use by licensed healthcare professionals and is not offered as or intended to be medical advice for any particular patient. This information is not intended for patients.

      Only a healthcare professional exercising independent clinical judgment can make decisions regarding appropriate patient care and treatment options considering the unique characteristics of each patient.

      Abbreviation: MDS; Movement disorder specialist. aPD; advanced Parkinson’s disease.
      References: 1. Antonini A, et al. Parkinsonism Relat Disord 2021 Nov;92:59-66. 2. Antonini A et al. Curr Med Res Opin 2018;34(12):2063–2073. 3. Antonini A et al. (2019) 23rd Annual International Congress of Parkinson’s Disease and Movement Disorders. Nice, France. Abstract 2142. 4. Antonini A et al. 2019. Poster presented at AAN, Philadelphia, PA. May 4–10, 2019.

      AU-NEUP-230057. June 2024.